Sabra Healthcare REIT, Inc. $SBRA Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System decreased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 622,962 shares of the real estate investment trust’s stock after selling 24,907 shares during the quarter. California Public Employees Retirement System’s holdings in Sabra Healthcare REIT were worth $11,980,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of SBRA. Focus Partners Wealth boosted its holdings in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the period. First Trust Advisors LP boosted its stake in shares of Sabra Healthcare REIT by 27.2% in the second quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after purchasing an additional 78,709 shares during the period. Cerity Partners LLC grew its holdings in Sabra Healthcare REIT by 73.0% during the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its holdings in Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after purchasing an additional 2,557 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 1.5%

NASDAQ SBRA opened at $22.36 on Friday. The company has a market capitalization of $5.64 billion, a price-to-earnings ratio of 35.49, a price-to-earnings-growth ratio of 1.57 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT, Inc. has a 12 month low of $17.17 and a 12 month high of $22.55. The company’s fifty day moving average price is $19.68 and its two-hundred day moving average price is $19.84.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. The company had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company’s revenue was up 20.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.4%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Cantor Fitzgerald raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Truist Financial lifted their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday. Citigroup reiterated a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Finally, Raymond James Financial assumed coverage on Sabra Healthcare REIT in a report on Wednesday, June 17th. They issued an “underperform” rating for the company. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.25.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.